6:19AM ShangPharma beats by $0.02; beats on revs (SHP) 12.50 : Reports Q1 (Mar) EPS per ADS of $0.23 vs $0.21 consensus; revs incresed 25.6% YoY to $24.8 mln vs $24.4 mln consensus. Co reaffirms guidance for FY11 (Dec), sees FY11 (Dec) revs of $111.1-115.6 mln vs. $113.43 mln Thomson Reuters consensus. Co sees FY capital expenditure to be $28-32 mln.